SES-CAB: Science, Evidence & Safety Clinical Advisory Board
Menu

Tag: NMPA regulations

Chinese Generic Production: Manufacturing and Quality Concerns in Global Pharma

Chinese Generic Production: Manufacturing and Quality Concerns in Global Pharma

  • Cheryl Moran
  • January 19, 2026
  • 11 Comments

China produces 80% of the world's generic drug ingredients, but quality concerns persist. Learn how cost-cutting, outdated tech, and weak oversight affect medicine safety-and why the global supply chain is at risk.

read more

Search Categories

  • Health & Medicine (230)
  • Health (4)

Our Archive

  • August 2026 (10)
  • July 2026 (15)
  • June 2026 (10)
  • May 2026 (14)
  • April 2026 (11)
  • March 2026 (11)
  • February 2026 (16)
  • January 2026 (25)
  • December 2025 (30)
  • November 2025 (21)
  • October 2025 (29)
  • September 2025 (32)

Search by Tags

medication safety online pharmacy generic drugs counterfeit drugs safe online pharmacy GoodRx coupons side effects dietary supplement medication adherence blood thinners drug interactions adaptogen DOACs polypharmacy drug interaction generic medications medication storage prior authorization OCD medication dosage

SES-CAB: Science, Evidence & Safety Clinical Advisory Board

© 2026. All rights reserved.

  • About
  • Privacy
  • Data Protection
  • Contact